Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics crawled date : 2020 - 12 - 03 save search
InMed Licenses MiDROPS Delivery Technology from EyeCRO for the Delivery of Therapeutic Cannabinoids
Published: 2020-12-03 (Crawled : 19:00) - biospace.com/
INM 4 | $0.281 -6.65% -7.12% 59K
|
Health Technology
|
| O: -0.55%
H: 9.53%
C: -3.16%
license eye liver drop
Karuna Therapeutics Appoints David Wheadon, M.D., to Its Board of Directors
Published: 2020-12-03 (Crawled : 16:00) - biospace.com/
KRTX | $329.83 0.0% 1.9M
|
Health Technology
|
| O: 0.79%
H: 0.21%
C: -3.02%
Horizon Therapeutics plc Provides $1 Million in Scholarships to Help Economically Disadvantaged Students and Students of Color Further Their Liberal Arts and Health Professions Education
Published: 2020-12-03 (Crawled : 16:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: 0.66%
H: 1.89%
C: 1.74%
education
Alnylam Completes Enrollment in ILLUMINATE-C Phase 3 Study of Lumasiran, an RNAi Therapeutic, for the Treatment of Advanced Primary Hyperoxaluria Type 1
Published: 2020-12-03 (Crawled : 16:00) - biospace.com/
ALNY | News | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 0.41%
H: 2.21%
C: 0.9%
phase 3 treatment enroll
Iterum Therapeutics Provides Update on Phase 3 Clinical Trials of Sulopenem in Complicated Urinary Tract Infection (cUTI) and Uncomplicated Urinary Tract Infection (uUTI)
Published: 2020-03-31 (Crawled : 15:41) - globenewswire.com
ITRM | $1.43 -0.69% 60K
|
Health Technology
|
| O: 1.79%
H: 1.75%
C: -4.91%
phase 3 trial sulopenem injection infections
Iterum Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference
Published: 2020-04-09 (Crawled : 15:41) - globenewswire.com
ITRM | $1.43 -0.69% 60K
|
Health Technology
| Email alert
Add to watchlist
annual needham annual needham virtual healthcare conference needham virtual healthcare conference
Iterum Therapeutics Reports First Quarter 2020 Financial Results
Published: 2020-05-14 (Crawled : 15:41) - globenewswire.com
ITRM | $1.43 -0.69% 60K
|
Health Technology
|
| O: -0.29%
H: 6.18%
C: 2.94%
results therapeutics
Iterum Therapeutics Announces Topline Results for a Phase 3 Clinical Trial of Oral and IV Sulopenem in Complicated Urinary Tract Infection
Published: 2020-06-01 (Crawled : 15:41) - globenewswire.com
ITRM | $1.43 -0.69% 60K
|
Health Technology
|
| O: -62.49%
H: 38.7%
C: 7.66%
results phase 3 trial sulopenem topline injection infections
Iterum Therapeutics Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Published: 2020-06-03 (Crawled : 15:40) - globenewswire.com
ITRM | $1.43 -0.69% 60K
|
Health Technology
|
| O: -0.62%
H: 2.48%
C: -7.45%
offering nasdaq
Iterum Therapeutics plc Announces Result of Proposal 8 at Annual General Meeting
Published: 2020-06-15 (Crawled : 15:40) - globenewswire.com
ITRM | $1.43 -0.69% 60K
|
Health Technology
|
| O: -1.95%
H: 3.17%
C: -0.66%
Iterum Therapeutics Announces Topline Results from its Phase 3 Clinical Trial of Oral Sulopenem for the Treatment of Uncomplicated Urinary Tract Infections
Published: 2020-06-29 (Crawled : 15:40) - globenewswire.com
ITRM | $1.43 -0.69% 60K
|
Health Technology
|
| O: -4.58%
H: 0.68%
C: -2.74%
results phase 3 trial sulopenem treatment topline injection infections
Iterum Therapeutics Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Published: 2020-06-30 (Crawled : 15:40) - globenewswire.com
ITRM | $1.43 -0.69% 60K
|
Health Technology
|
| O: -7.75%
H: 3.82%
C: -9.16%
offering nasdaq
Iterum Therapeutics Informs Shareholders of Record Date for Planned Rights Offering
Published: 2020-07-13 (Crawled : 15:40) - globenewswire.com
ITRM | $1.43 -0.69% 60K
|
Health Technology
|
| O: -11.5%
H: 3.0%
C: 0.0%
offering
Iterum Therapeutics Reports Second Quarter 2020 Financial Results
Published: 2020-08-06 (Crawled : 15:40) - globenewswire.com
ITRM | $1.43 -0.69% 60K
|
Health Technology
|
| O: -0.96%
H: 1.94%
C: 0.67%
results therapeutics
Iterum Therapeutics Commences Rights Offering
Published: 2020-08-11 (Crawled : 15:40) - globenewswire.com
ITRM | $1.43 -0.69% 60K
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: -3.43%
offering therapeutics
Iterum Therapeutics Announces Expiration and Preliminary Results of Rights Offering
Published: 2020-09-01 (Crawled : 15:40) - globenewswire.com
ITRM | $1.43 -0.69% 60K
|
Health Technology
|
| O: -2.56%
H: 3.16%
C: -3.95%
offering results therapeutics
Iterum Therapeutics Announces Revised Results of Rights Offering
Published: 2020-09-02 (Crawled : 15:40) - globenewswire.com
ITRM | $1.43 -0.69% 60K
|
Health Technology
|
| O: -2.6%
H: 1.27%
C: -4.51%
offering results therapeutics
Iterum Therapeutics to Present at the 22nd Annual H.C. Wainwright Global Investment Conference
Published: 2020-09-08 (Crawled : 15:40) - globenewswire.com
ITRM | $1.43 -0.69% 60K
|
Health Technology
|
| O: -1.15%
H: 5.09%
C: 4.9%
Iterum Therapeutics Announces Positive Pre-NDA Meeting with FDA for Sulopenem for Treatment of Uncomplicated Urinary Tract Infections
Published: 2020-09-30 (Crawled : 15:40) - globenewswire.com
ITRM | $1.43 -0.69% 60K
|
Health Technology
|
| O: 155.13%
H: 48.78%
C: -35.98%
positive fda sulopenem treatment injection infections
Iterum Therapeutics to Present Data from Phase 3 Trials in Uncomplicated and Complicated Urinary Tract Infections at IDWeek 2020
Published: 2020-10-19 (Crawled : 15:40) - globenewswire.com
ITRM | $1.43 -0.69% 60K
|
Health Technology
|
| O: 27.76%
H: 27.07%
C: 5.89%
phase 3 trial injection infections
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.